Protease Inhibitor Vs. Raltegravir-based ART and Inflammation in HIV Infection
NCT02691065
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
Integrase Inhibitor
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborators
[object Object]